These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12176432)

  • 1. FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen.
    Shibutani S; Akiyama Y; Shirasugi N; Matsumoto K; Kitajima M; Aramaki O; Yokoyama T; Kan S; Ikeda Y; Niimi M
    Transplant Proc; 2002 Aug; 34(5):1445. PubMed ID: 12176432
    [No Abstract]   [Full Text] [Related]  

  • 2. CD25+ regulatory cells generated by intratracheal delivery of alloantigen.
    Akiyama Y; Shibutani S; Matsumoto K; Kitajima M; Aramaki O; Yokoyama T; Kan S; Ikeda Y; Shirasugi N; Niimi M
    Transplant Proc; 2002 Aug; 34(5):1443-4. PubMed ID: 12176431
    [No Abstract]   [Full Text] [Related]  

  • 3. B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice.
    Akiyama Y; Shirasugi N; Uchida N; Matsumoto K; Kitajima M; Bashuda H; Yagita H; Okumura K; Aramaki O; Niimi M
    Transplantation; 2002 Sep; 74(5):732-8. PubMed ID: 12352894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
    Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M
    Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of alveolar macrophages abrogates prolongation of cardiac allograft survival induced by intratracheal delivery of alloantigen.
    Iwami D; Zhang Q; Aramaki O; Matsuno K; Nonomura K; Shirasugi N; Niimi M
    Transplantation; 2011 Feb; 91(4):413-24. PubMed ID: 21192321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various costimulatory pathways are essential for induction of regulatory cells by intratracheal delivery of alloantigen.
    Aramaki O; Inoue F; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Okumura K; Yagita H; Shirasugi N; Niimi M
    Transplant Proc; 2005 May; 37(4):1934-6. PubMed ID: 15919509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
    de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL
    Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival of fully allogeneic cardiac allografts induced by delivery of alloantigen via respiratory mucosa is abrogated by blockade of the B7 pathway.
    Shirasugi N; Matsumoto S; Hamano K; Esato K; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Takami H; Kodaira S; Niimi M
    Transplant Proc; 2000 Nov; 32(7):2034. PubMed ID: 11120053
    [No Abstract]   [Full Text] [Related]  

  • 9. Duration of donor-specific tolerance after intrathymic administration of alloantigen.
    Arima T; Nakafusa Y; Goss JA; Walp LA; Yu S; Flye MW
    Transplant Proc; 1995 Feb; 27(1):136-7. PubMed ID: 7878912
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.
    Shibutani S; Inoue F; Aramaki O; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Ikeda Y; Shirasugi N; Niimi M
    Transplantation; 2005 Apr; 79(8):904-13. PubMed ID: 15849542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen.
    Aramaki O; Shirasugi N; Akiyama Y; Shibutani S; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Okumura K; Yagita H; Niimi M
    Transplantation; 2003 Sep; 76(5):772-6. PubMed ID: 14501851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2035. PubMed ID: 11120054
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of hyporesponsiveness to fully allogeneic cardiac grafts by intratracheal delivery of alloantigen.
    Shirasugi N; Ikeda Y; Akiyama Y; Matsumoto K; Hamano K; Esato K; Bashuda H; Yagita H; Okumura K; Takami H; Kodaira S; Niimi M
    Transplantation; 2001 Feb; 71(4):561-4. PubMed ID: 11258436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indefinite survival of fully allogeneic cardiac grafts induced by antigen delivery through the alimentary tract.
    Niimi M; Ikeda Y; Kan S; Shirasugi N; Hamano K
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):629-30. PubMed ID: 11547327
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Mar; 32(2):259. PubMed ID: 10715410
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathymic inoculation of donor B cells prolongs cardiac allograft survival by non-deletional mechanisms.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):94. PubMed ID: 10083024
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
    Nakafusa Y; Arima T; Goss JA; Flye MW
    Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
    [No Abstract]   [Full Text] [Related]  

  • 19. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
    Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
    Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.